Arialys Therapeutics
Clinical trials sponsored by Arialys Therapeutics, explained in plain language.
-
New antibody drug aims to block brain attacks in autoimmune encephalitis
Disease control CompletedThis early-stage trial tested a new drug called ART5803 in 64 healthy adults to see if it is safe. ART5803 is a lab-made antibody designed to block harmful immune proteins that attack the brain in autoimmune encephalitis. The study gave single or multiple doses and compared them …
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Healthy volunteers help test new drug for brain inflammation
Knowledge-focused CompletedThis early-stage study tested a single dose of a new drug called ART5803 in 7 healthy adults to see if it is safe and how it interacts with another medicine (IVIG). The goal was to gather information for future research on autoimmune encephalitis, a condition where the immune sys…
Phase: PHASE1 • Sponsor: Arialys Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC